Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Limbach Holdings, Inc. (LMB)
NASDAQIndustrialsConstruction MaterialsSnapshot 2026-11-04
$54.50-6.21%
Close 2026-11-05 · 1-day change
NASDAQIndustrialsConstruction MaterialsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.65 → 4.65 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for LMB yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS near $4.74 in 2026 | A primary condition in Limbach Holdings, Inc.'s published investment case. The stated target is >= $4.74 per share. | Broken | EPS falls below $4.74 in 2026 | Diluted EPS: $0.79 per share FY2026-Q3; GAAP. Published target: >= $4.74 per share. Annual target cannot be compared with a quarterly or TTM observation. Nov 3, 20260.79 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a growth-focused business with a mixed execution record, rather than a steady compounder. The long-term thesis is intact but fragile: revenue and owner-direct growth are on track, while management execution is volatile and the current thesis state is watch.
Valuation is described as cheap versus peers, and the priced-in assessment calls expectations justified rather than highly fragile. Still, the valuation measure rose recently, while the expectations gap is negative, suggesting the market does not fully reflect the weak execution picture.
Near term, revenue growth has been strong and FY 2026 revenue guidance was raised, with owner-direct revenue also growing. Profitability is less secure: adjusted EBITDA fell year over year and its FY 2026 guidance was cut, leaving earnings quality fragile amid sector headwinds.
The multi-year thesis depends on LMB delivering its raised revenue guidance while stabilizing adjusted EBITDA. A further guidance cut would damage management credibility; results and guidance from sector peers could either sustain or weaken the sector backdrop.
Over the next 1 to 3 years, LMB’s growth progress is balanced by lower profitability, elevated risk, and a recent record of performance below its industry cohort. The thesis remains watchful and depends on execution and sector conditions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| New COO may improve operations. |
| Improving |
| No operational improvements after COO appointment within 1 year |
Book-to-bill 1.4x vs qualitative target New COO appointed May 2026. Q3 2026 earnings beat with 1.4x book-to-bill and unchanged guidance. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Annual revenue at least $730M in 2026 | A primary condition in Limbach Holdings, Inc.'s published investment case. The stated target is >= $730 million. | Intact | Annual revenue falls below $730 million in 2026 | Revenue: $230.46M FY2026-Q3; GAAP. Published target: >= $730 million. Annual target cannot be compared with a quarterly or TTM observation. Nov 3, 2026230,460,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Share repurchase program up to $50M | A supporting condition in Limbach Holdings, Inc.'s published investment case. The stated target is Repurchase up to $50 million shares authorized. | Intact | Buyback program is canceled or unused after 12 months | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$5.09 → $4.65 · observed estimates
$0.79B → $0.90B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-07-25 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-07-26 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-07-27 | $5.09 | $786,201,084 | 4 / 4 |
| 2026-07-28 | $5.09 | $786,201,084 | 4 / 4 |
| 2026-07-29 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-07-30 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-07-31 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-08-01 | $5.09 | $786,201,084 | 4 / 4 |
| 2026-08-02 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-08-03 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-08-04 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-08-05 | $5.09 | $786,201,080 | 5 / 5 |
| 2026-08-06 | $5.09 | $786,201,084 | 4 / 4 |
| 2026-08-07 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-08 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-09 | $4.78 | $811,556,700 | 4 / 5 |
| 2026-08-10 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-12 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-13 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-14 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-15 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-16 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-17 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-18 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-19 | $5.01 | $795,936,600 | 4 / 4 |
| 2026-08-20 | $4.39 | $818,563,600 | 4 / 4 |
| 2026-08-21 | $4.39 | $818,563,600 | 4 / 4 |
| 2026-08-22 | $4.39 | $818,563,600 | 4 / 4 |
| 2026-08-23 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-08-24 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-08-25 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-08-26 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-08-27 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-08-28 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-08-29 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-08-30 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-08-31 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-09-01 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-09-02 | $4.27 | $818,635,297 | 4 / 4 |
| 2026-09-03 | $4.34 | $846,763,600 | 4 / 4 |
| 2026-09-04 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-05 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-06 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-07 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-08 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-09 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-10 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-11 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-12 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-13 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-14 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-15 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-16 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-17 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-18 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-19 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-20 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-21 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-22 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-23 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-24 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-25 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-26 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-27 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-28 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-29 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-09-30 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-01 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-02 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-03 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-04 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-05 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-06 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-07 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-08 | $4.65 | $901,823,600 | 3 / 3 |
| 2026-10-09 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-10 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-11 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-12 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-13 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-14 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-15 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-16 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-17 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-18 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-19 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-20 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-21 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-22 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-23 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-24 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-25 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-26 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-27 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-28 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-29 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-30 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-10-31 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-11-01 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-11-02 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-11-03 | $4.65 | $901,823,540 | 3 / 3 |
| 2026-11-04 | $4.65 | $901,823,540 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 0 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.